'Just getting started': Inside Regeneron's multibillion-dollar push for the next generation of medicine

News 12
9 followers
Nov 16, 2026
It wasn't long ago the world was looking for answers about COVID.
Why can't you give this medication
to someone in the hospital right now?
Today, the conversation has changed.
I see it's an active lab right now.
And so has the science.
What scientific breakthrough has you most excited today
that maybe wasn't on your radar when we last spoke?
We're using now these new kinds of medicines
to actually change or give back broken or missing genes.
We sat down exclusively with Dr. George Ancompoulos, co-founder,
president, and chief scientific officer of Regeneron,
where one of its newest breakthroughs is a gene therapy
for children born with a rare form of genetic deafness.
This gene therapy in more than half
the children restored normal hearing. It's really life-changing.
And that's just one frontier.
We've already announced some exciting early data
that we've had where we can co-treat people.
With weight loss drugs,
but also with muscle preservation agents that we've invented here,
that can stave off much of the muscle loss.
His work has also taken him from the lab to the White House.
Regeneron will be giving this away for free.
In April, Young Ancompoulos has joined President Trump
as Regeneron announced a new drug pricing
agreement aimed at lowering costs for American patients.
Here we are now six months in.
Would you say that that initiative is working?
I do think the administration...
...had a really good intent and effort in what they were trying to do.
Because, of course, we all want to try to control the cost of drugs.
But we can't do that at the cost of hampering or impairing innovation.
And if the other countries start paying their fair share,
their prices go up and the prices in America come down.
All of it happening as Regeneron continues
a multi-billion dollar expansion
of its sprawling Tarrytown campus.
And for Young Ancompoulos,
Four decades into a career spent trying
to solve some of medicine's hardest problems.
I feel like I'm just getting started.
Tara Rosenblum, News 12.
